158 related articles for article (PubMed ID: 36224342)
21. The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF.
Figueroa L; Xiong Y; Song C; Piao W; Vogel SN; Medvedev AE
J Immunol; 2012 May; 188(9):4506-15. PubMed ID: 22474023
[TBL] [Abstract][Full Text] [Related]
22. Regulator of calcineurin 1 differentially regulates TLR-dependent MyD88 and TRIF signaling pathways.
Pang Z; Junkins RD; Raudonis R; MacNeil AJ; McCormick C; Cheng Z; Lin TJ
PLoS One; 2018; 13(5):e0197491. PubMed ID: 29799862
[TBL] [Abstract][Full Text] [Related]
23. Anti-inflammatory action of 2-carbomethoxy-2,3-epoxy-3-prenyl-1,4-naphthoquinone (CMEP-NQ) suppresses both the MyD88-dependent and TRIF-dependent pathways of TLR4 signaling in LPS-stimulated RAW264.7 cells.
Ju Woo H; Jun DY; Lee JY; Park HS; Woo MH; Park SJ; Kim SC; Yang CH; Kim YH
J Ethnopharmacol; 2017 Jun; 205():103-115. PubMed ID: 28465253
[TBL] [Abstract][Full Text] [Related]
24. Roles of Toll-like receptors in allogeneic islet transplantation.
Ro H; Hong J; Kim BS; Lee EW; Kim MG; Han KH; Yeom HJ; Lee EM; Jeong JC; Oh KH; Ahn C; Yang J
Transplantation; 2012 Nov; 94(10):1005-12. PubMed ID: 23169223
[TBL] [Abstract][Full Text] [Related]
25. MyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvant.
Orr MT; Duthie MS; Windish HP; Lucas EA; Guderian JA; Hudson TE; Shaverdian N; O'Donnell J; Desbien AL; Reed SG; Coler RN
Eur J Immunol; 2013 Sep; 43(9):2398-408. PubMed ID: 23716300
[TBL] [Abstract][Full Text] [Related]
26. Recruitment of TLR adapter TRIF to TLR4 signaling complex is mediated by the second helical region of TRIF TIR domain.
Piao W; Ru LW; Piepenbrink KH; Sundberg EJ; Vogel SN; Toshchakov VY
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):19036-41. PubMed ID: 24194546
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of myeloid differentiation primary response 88 and Toll-like receptor 4 in breast cancer patients.
Ma FJ; Liu ZB; Hu X; Ling H; Li S; Wu J; Shao ZM
PLoS One; 2014; 9(10):e111639. PubMed ID: 25360699
[TBL] [Abstract][Full Text] [Related]
28. A role for the adaptor proteins TRAM and TRIF in toll-like receptor 2 signaling.
Nilsen NJ; Vladimer GI; Stenvik J; Orning MP; Zeid-Kilani MV; Bugge M; Bergstroem B; Conlon J; Husebye H; Hise AG; Fitzgerald KA; Espevik T; Lien E
J Biol Chem; 2015 Feb; 290(6):3209-22. PubMed ID: 25505250
[TBL] [Abstract][Full Text] [Related]
29. CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance.
Rajaiah R; Perkins DJ; Ireland DD; Vogel SN
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8391-6. PubMed ID: 26106158
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of TLR4/TRIF/IRF3 Signaling Pathway by Curcumin in Breast Cancer Cells.
Güney Eskiler G; Deveci Özkan A; Kaleli S; Bilir C
J Pharm Pharm Sci; 2019; 22(1):281-291. PubMed ID: 31287789
[TBL] [Abstract][Full Text] [Related]
31. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S
Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817
[TBL] [Abstract][Full Text] [Related]
32. TRIF signaling is essential for TLR4-driven IgE class switching.
Janssen E; Ozcan E; Liadaki K; Jabara HH; Manis J; Ullas S; Akira S; Fitzgerald KA; Golenbock DT; Geha RS
J Immunol; 2014 Mar; 192(6):2651-8. PubMed ID: 24532577
[TBL] [Abstract][Full Text] [Related]
33. Human Binge Alcohol Intake Inhibits TLR4-MyD88 and TLR4-TRIF Responses but Not the TLR3-TRIF Pathway: HspA1A and PP1 Play Selective Regulatory Roles.
Muralidharan S; Lim A; Catalano D; Mandrekar P
J Immunol; 2018 Apr; 200(7):2291-2303. PubMed ID: 29445009
[TBL] [Abstract][Full Text] [Related]
34. TLR-4 signalling pathway: MyD88 independent pathway up-regulation in chicken breeds upon LPS treatment.
Karnati HK; Pasupuleti SR; Kandi R; Undi RB; Sahu I; Kannaki TR; Subbiah M; Gutti RK
Vet Res Commun; 2015 Mar; 39(1):73-8. PubMed ID: 25417198
[TBL] [Abstract][Full Text] [Related]
35. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects.
Dasu MR; Devaraj S; Park S; Jialal I
Diabetes Care; 2010 Apr; 33(4):861-8. PubMed ID: 20067962
[TBL] [Abstract][Full Text] [Related]
36. TLR4-HMGB1-, MyD88- and TRIF-dependent signaling in mouse intestinal ischemia/reperfusion injury.
Wang J; He GZ; Wang YK; Zhu QK; Chen W; Guo T
World J Gastroenterol; 2015 Jul; 21(27):8314-25. PubMed ID: 26217083
[TBL] [Abstract][Full Text] [Related]
37. Absence of TRAM restricts Toll-like receptor 4 signaling in vascular endothelial cells to the MyD88 pathway.
Harari OA; Alcaide P; Ahl D; Luscinskas FW; Liao JK
Circ Res; 2006 May; 98(9):1134-40. PubMed ID: 16574902
[TBL] [Abstract][Full Text] [Related]
38. LPS-mediated activation of TLR4 controls Toxoplasma gondii growth in human trophoblast cell (BeWo) and human villous explants in a dependent-manner of TRIF, MyD88, NF-κB and cytokines.
Rosini AM; Teixeira SC; Milian ICB; Silva RJ; de Souza G; Luz LC; Gomes AO; Mineo JR; Mineo TWP; Ferro EAV; Barbosa BF
Tissue Cell; 2022 Oct; 78():101907. PubMed ID: 36037656
[TBL] [Abstract][Full Text] [Related]
39. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex.
Youn HS; Lee JY; Fitzgerald KA; Young HA; Akira S; Hwang DH
J Immunol; 2005 Sep; 175(5):3339-46. PubMed ID: 16116226
[TBL] [Abstract][Full Text] [Related]
40. Differential involvement of BB loops of toll-IL-1 resistance (TIR) domain-containing adapter proteins in TLR4- versus TLR2-mediated signal transduction.
Toshchakov VU; Basu S; Fenton MJ; Vogel SN
J Immunol; 2005 Jul; 175(1):494-500. PubMed ID: 15972684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]